| Literature DB >> 28504697 |
Jing Geng1, Shujuan Yu1, Hao Zhao1, Xiufeng Sun1, Xun Li2, Ping Wang1, Xiaolin Xiong1, Lixin Hong1, Changchuan Xie1, Jiahui Gao1, Yiran Shi1, Jiaqi Peng1, Randy L Johnson3, Nengming Xiao1, Linrong Lu4,5, Jiahuai Han1, Dawang Zhou1, Lanfen Chen1.
Abstract
An imbalance in the lineages of immunosuppressive regulatory T cells (Treg cells) and the inflammatory TH17 subset of helper T cells leads to the development of autoimmune and/or inflammatory disease. Here we found that TAZ, a coactivator of TEAD transcription factors of Hippo signaling, was expressed under TH17 cell-inducing conditions and was required for TH17 differentiation and TH17 cell-mediated inflammatory diseases. TAZ was a critical co-activator of the TH17-defining transcription factor RORγt. In addition, TAZ attenuated Treg cell development by decreasing acetylation of the Treg cell master regulator Foxp3 mediated by the histone acetyltransferase Tip60, which targeted Foxp3 for proteasomal degradation. In contrast, under Treg cell-skewing conditions, TEAD1 expression and sequestration of TAZ from the transcription factors RORγt and Foxp3 promoted Treg cell differentiation. Furthermore, deficiency in TAZ or overexpression of TEAD1 induced Treg cell differentiation, whereas expression of a transgene encoding TAZ or activation of TAZ directed TH17 cell differentiation. Our results demonstrate a pivotal role for TAZ in regulating the differentiation of Treg cells and TH17 cells.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28504697 DOI: 10.1038/ni.3748
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606